These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12619364)

  • 1. [Generous treatment with gastric acid blockers. For patients with gastric reflux the proton pump inhibitor power is cost-effective].
    MMW Fortschr Med; 2003 Feb; 145(6):56-7. PubMed ID: 12619364
    [No Abstract]   [Full Text] [Related]  

  • 2. [Short-term intervention in ulcer and reflux. New acid blocker halves duration of therapy].
    Einecke D
    MMW Fortschr Med; 2000 Jul; 142(26-27):50-1. PubMed ID: 10929487
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office].
    Dohmen W; Fuchs W
    MMW Fortschr Med; 2005 Mar; 147(9):39. PubMed ID: 15794353
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of recurrent erosive reflux esophagitis].
    Müller P; Simon B
    Fortschr Med; 1997 Oct; 115(30):46-7. PubMed ID: 9453943
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acid inhibitors for asthma patients].
    Füessl HS
    MMW Fortschr Med; 2005 Oct; 147(42):4-5. PubMed ID: 16281772
    [No Abstract]   [Full Text] [Related]  

  • 6. All PPIs equivalent for treatment of GERD.
    J Fam Pract; 2005 Dec; 54(12):1024. PubMed ID: 16370078
    [No Abstract]   [Full Text] [Related]  

  • 7. Heartburn treatment in primary care. Prescribing omeprazole would conflict with desire to control prescribing costs.
    Williams A
    BMJ; 2000 May; 320(7246):1406-7. PubMed ID: 10858061
    [No Abstract]   [Full Text] [Related]  

  • 8. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
    Katz PO
    Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Maintenance therapy in reflux esophagitis].
    Katsoulis S; Fölsch UR
    Z Gastroenterol; 1997 Feb; 35(2):159-61. PubMed ID: 9163230
    [No Abstract]   [Full Text] [Related]  

  • 10. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment interruptus: the need for withdrawal.
    Hassall E
    Am J Gastroenterol; 2007 Sep; 102(9):2108-9. PubMed ID: 17727443
    [No Abstract]   [Full Text] [Related]  

  • 12. [Omeprazole is more cost-effective than ranitidine in reflux esophagitis].
    Lindberg G; Jönsson B
    Lakartidningen; 1992 Jul; 89(30-31):2530-3. PubMed ID: 1507987
    [No Abstract]   [Full Text] [Related]  

  • 13. [Safety of proton pump inhibitors for long-term application].
    Kuipers E
    Eksp Klin Gastroenterol; 2006; (4):48-52. PubMed ID: 17269424
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term therapy with omeprazole: when will it finally be approved?].
    Koop H
    Leber Magen Darm; 1995 Jul; 25(4):153-4. PubMed ID: 7564865
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.
    Lin HJ; Lo WC; Cheng YC; Perng CL
    Am J Gastroenterol; 2006 Mar; 101(3):500-5. PubMed ID: 16542286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis of maintenance proton pump inhibition.
    Harris RA; Kuppermann M; Richter JE
    Am J Med; 1997 Jan; 102(1):78-88. PubMed ID: 9209204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing concerns about chronic proton pump inhibitor use.
    Svoboda AC
    J Clin Gastroenterol; 2001 Jul; 33(1):3-7. PubMed ID: 11418781
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura.
    Tsutsumi Y; Kanamori H; Yamato H; Ehira N; Kawamura T; Umehara S; Mori A; Obara S; Ogura N; Tanaka J; Asaka M; Imamura M; Masauzi N
    Ann Hematol; 2005 Nov; 84(12):807-11. PubMed ID: 16078036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage.
    Spiegel BM; Dulai GS; Lim BS; Mann N; Kanwal F; Gralnek IM
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):988-997. PubMed ID: 16844422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.